Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7ZZO

HDAC2 in complex with an inhibitor

Summary for 7ZZO
Entry DOI10.2210/pdb7zzo/pdb
DescriptorHistone deacetylase 2, ZINC ION, CALCIUM ION, ... (9 entities in total)
Functional Keywordshistone deacetylase, chromatin binding, protein complex, transcription regulation, transcription
Biological sourceHomo sapiens (human)
Total number of polymer chains3
Total formula weight171313.81
Authors
Cleasby, A.,Tisi, D. (deposition date: 2022-05-25, release date: 2022-09-21, Last modification date: 2024-06-19)
Primary citationTamanini, E.,Miyamura, S.,Buck, I.M.,Cons, B.D.,Dawson, L.,East, C.,Futamura, T.,Goto, S.,Griffiths-Jones, C.,Hashimoto, T.,Heightman, T.D.,Ishikawa, S.,Ito, H.,Kaneko, Y.,Kawato, T.,Kondo, K.,Kurihara, N.,McCarthy, J.M.,Mori, Y.,Nagase, T.,Nakaishi, Y.,Reeks, J.,Sato, A.,Schopf, P.,Tai, K.,Tamai, T.,Tisi, D.,Woolford, A.J.
Fragment-Based Discovery of a Novel, Brain Penetrant, Orally Active HDAC2 Inhibitor.
Acs Med.Chem.Lett., 13:1591-1597, 2022
Cited by
PubMed Abstract: Fragment-based ligand discovery was successfully applied to histone deacetylase HDAC2. In addition to the anticipated hydroxamic acid- and benzamide-based fragment screening hits, a low affinity (∼1 mM) α-amino-amide zinc binding fragment was identified, as well as fragments binding to other regions of the catalytic site. This alternative zinc-binding fragment was further optimized, guided by the structural information from protein-ligand complex X-ray structures, into a sub-μM, brain penetrant, HDAC2 inhibitor () capable of modulating histone acetylation levels .
PubMed: 36262388
DOI: 10.1021/acsmedchemlett.2c00272
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon